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C-reactive protein (CRP) is an evolutionarily conserved protein. From arthropods to
humans, CRP has been found in every organism where the presence of CRP has been
sought. Human CRP is a pentamer made up of five identical subunits which binds to
phosphocholine (PCh) in a Ca2+ -dependent manner. In various species, we define a
protein as CRP if it has any two of the following three characteristics: First, it is a cyclic
oligomer of almost identical subunits of molecular weight 20–30 kDa. Second, it binds
to PCh in a Ca2+ -dependent manner. Third, it exhibits immunological cross-reactivity
with human CRP. In the arthropod horseshoe crab, CRP is a constitutively expressed
protein, while in humans, CRP is an acute phase plasma protein and a component
of the acute phase response. As the nature of CRP gene expression evolved from a
constitutively expressed protein in arthropods to an acute phase protein in humans,
the definition of CRP became distinctive. In humans, CRP can be distinguished from
other homologous proteins such as serum amyloid P, but this is not the case for most
other vertebrates and invertebrates. Literature indicates that the binding ability of CRP
to PCh is less relevant than its binding to other ligands. Human CRP displays structurebased ligand-binding specificities, but it is not known if that is true for invertebrate CRP.
During evolution, changes in the intrachain disulfide and interchain disulfide bonds and
changes in the glycosylation status of CRP may be responsible for different structurefunction relationships of CRP in various species. More studies of invertebrate CRP are
needed to understand the reasons behind such evolution of CRP. Also, CRP evolved as
a component of and along with the development of the immune system. It is important
to understand the biology of ancient CRP molecules because the knowledge could be
useful for immunodeficient individuals.
Keywords: C-reactive protein, pentraxin, serum amyloid P, phosphocholine, PTX3

INTRODUCTION
Human C-reactive protein (CRP) was identified as a plasma protein which, in the presence of Ca2+ ,
precipitated C-polysaccharide (PnC) isolated from the cell wall of Streptococcus pneumoniae (1).
The precipitation was due to the binding of CRP to phosphocholine (PCh) moiety present in PnC
(2). In animals, we define a protein as CRP if it has at least two of the following three characteristics:
First, it is a cyclic oligomer of almost identical subunits of molecular weight 20–30 kDa. Second, it
binds to PCh in a Ca2+ -dependent manner. Third, it exhibits immunological cross-reactivity with
human CRP.
CRP is an evolutionarily conserved protein. From arthropods to humans, CRP has been found
in every organism where the presence of CRP has been sought (3–8). In the arthropod horseshoe
crab, CRP is a constitutively expressed protein found in the hemolymph (8). After ∼500 million
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years of evolution, in humans and some other species, CRP
became a protein which is expressed as a component of
the acute phase response (9). The aim of this paper was
to review the changes observed in the structure and ligandbinding specificities of CRP during evolution. We reviewed
the literature on the structure and ligand-binding specificities
of CRP from the following animals from arthropods to
humans: American horseshoe crab, giant African snail, 17
different species of fish, chicken, frog, cow, dog, guinea pig,
horse, hamster, mouse, goat, rat, rabbit, monkey, pig, mink,
elephant, squirrel, seal, phascogale, and man. We compared the
primary structure of CRP and searched for the conservation
of functionally critical amino acid residues that are known
for human CRP (Figure 1). We also compared the overall
quaternary structure (Table 1), ligand-binding specificities, and
immunological cross-reactivity of CRP (Table 2), if known. Two
other proteins, serum amyloid P component (SAP), also known
as pentraxin-2, and long pentraxin (PTX3), which share several
structural and functional properties with CRP, are not reviewed
here (3, 56).

CRP IN AN ARTHROPOD
A protein that fits the definition of CRP is present in the
hemolymph of the arthropod American horseshoe crab, Limulus
polyphemus (5, 6, 10–13, 57–59). Limulus CRP binds to PCh
in a Ca2+ -dependent manner and precipitates PnC. Limulus
CRP exhibits immunological cross-reactivity against snail CRP;
the cross-reactivity against human CRP and rabbit CRP is
weak. Limulus CRP is made of three types of subunits,
each subunit having 218 amino acid residues, encoded by
three homologous genes. The three subunits, which share
an identical N-terminal sequence of 44 amino acid residues
and a C-terminal sequence from amino acid residues 206–
218, exist approximately in equimolar amount and are tightly
associated. Hexagonal Limulus CRP, as revealed by electron
microscopy, consists of two copies of each type of subunit.
The positions of six half-cystines that form three intrachain
disulfide bonds and the site of glycosylation are constant in
all subunits. The molecular weight of Limulus CRP is ∼300
kDa. The molecular weight of the subunits is ∼25 kDa.
Thus, there are 12 subunits in one Limulus CRP molecule,
that is, two hexamers stacked together. The concentration
of CRP in Limulus hemolymph is ∼2.0 mg/ml. It remains
to be determined whether Limulus CRP is an acute phase
protein. Limulus CRP has also been shown to chelate the heavy
metals mercury and cadmium, and hence playing a role in
detoxification of heavy metals. Such a detoxification function
of Limulus CRP is not known for human CRP. Uniquely,
Limulus CRP has also been shown to exhibit Ca2+ -independent
binding to membranes mimicking the outer membrane of
Gram-negative bacteria and then create pores in the lipid
bilayer (5, 6, 10–13, 57–59).

FIGURE 1 | Alignment of the primary structure of CRP from various species
using Clustal Omega (1.2.4) EMBL-EBI multiple sequence alignment software.
Sequences were obtained from NCBI in FASTA format and copied into the
EMBL-EBI alignment software where the output result was obtained in the
format of ClustalW with character counts. For horse and horseshoe crab,
there were several sequences due to the presence of isoforms. Since the
microheterogeneity between these isoforms was <10%, the first isoform
sequence was selected. Accession numbers of the sequences are: Horseshoe
crab, AAA28270; Rainbow trout, NP001118197.1; Goldfish, AK022072.1;
(Continued)

Abbreviations: CRP, C-reactive protein; FP, female protein; LDL, low density
lipoprotein; PCh, phosphocholine; PnC, pneumococcal C-polysaccharide; SAP,
serum amyloid P component.
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weight of lumpsucker CRP is in the range of 125 and 150 kDa.
Lumpsucker CRP consists of identical, non-covalently bound
subunits of molecular weight 20–21.5 kDa.
CRP is also present in the sera of another teleost, the rainbow
trout species, Salmo gairdneri and Oncorhynchus mykiss (22, 63–
67). Trout CRP binds to PCh in a Ca2+ -dependent manner,
precipitates PnC, is a glycoprotein, and has 179 amino acid
residues. According to one study, the molecular weight of
rainbow trout CRP is 110 kDa, while that of the subunits is
∼20 kDa. According to another study, the molecular weight of
rainbow trout CRP is 81.4 kDa, it is a trimer, and composed
of one monomer subunit (26.6 kDa) and one disulfide-linked
dimer (43.7 kDa). However, there exists the possibility that a
hexamer or a double-stacked hexamer was separated into two or
four trimers. The CRP level in normal trout sera is in the range
of 30–88 µg/ml. Trout CRP is an acute phase protein because
its concentration increases in response to toxic chemicals and
bacterial pathogens (22, 63–67). Cod, Gadus morhua, CRP that
exhibits Ca2+ -dependent binding to PCh, is glycosylated, and is
a pentamer in its electron microscopic appearance. The size of the
subunits in cod CRP varies in the range of 22–29 kDa (23, 24).
Among other teleosts, CRP has been isolated from the sera of
eels Anguilla anguilla and Anguilla japonica (25, 26). Eel CRP
binds to PCh in a Ca2+ -dependent manner and agglutinates S.
pneumoniae. The molecular weight of eel CRP is 120 kDa and
the subunits are non-glycosylated, with a molecular weight of 24
kDa. The serum levels of eel CRP is ∼1 µg/ml. CRP is present
in channel catfish Ictalurus punctatus (27). Catfish CRP binds to
PCh and precipitates PnC in a Ca2+ -dependent manner. Catfish
CRP is a non-glycosylated protein with a molecular weight of
∼100 kDa. Electron microscopy has shown that catfish CRP
has a planar pentagonal symmetry. The serum titer of catfish
CRP follows an acute phase pattern in catfish injected with
turpentine. Striped catfish, Pangasianodon hypophthalmus, CRP
binds to PCh in a Ca2+ -dependent manner, is a trimer of 28 kDa
subunits, can exist as tetramers of trimers, is devoid of interchain
disulfide bonds, is glycosylated, and agglutinates a few species
of pathogenic bacteria (28). A CRP gene in ayu, Plecoglossus
altivelis, has been identified (29). The expression of ayu CRP is
upregulated following bacterial infection. Ayu CRP agglutinates
both gram negative and positive bacteria in a Ca2+ -dependent
manner. Ayu CRP is not glycosylated, has a molecular weight of
25.2 kDa, and has 225 amino acid residues.
In cyprinids, the carp family fish rohu, Labeo rohita, CRP has
been purified by their Ca2+ -dependent binding to PCh (30, 68,
69). There are three types of glycosylated subunits in rohu CRP,
and all three types of subunits move to identical position after
desialylation and deglycosylation. Rohu CRP appears pentameric
under electron microscope and is composed of identical subunits
of molecular weight 33 kDa. Rohu CRP is an acute phase
protein because its concentration in serum increases in response
to heavy metal poisoning of water. In common carp Cyprinus
carpio, CRP CRP displays Ca2+ -dependent binding to phosphate
monoesters (31, 37, 70–72). Common carp CRP is glycosylated,
has 208 amino acid residues, and the molecular weight of the
subunits is 27 kDa. A potential commercial use of CRP, which
is constitutively expressed in common carp, is as a biomarker of

FIGURE 1 | Common carp, AEU04519; Zebrafish, AGB69036; Rockfish,
AKR17056; Tonguefish, NP001281151; Salmon, NP001134140; Chicken,
ABD16281; Frog, NP001165686; Pig, NP999009; Horse, XP001504452;
Dog, CDF47287; Monkey, XP001117250; Rabbit, NP001075734; Squirrel,
XP026263752.1; Guinea pig, AAC60662; Elephant, XP006895510.1; Mouse,
AFA37877; Hamster, XP005078251; Rat, AFA37869; Goat, XP017901842;
Cow, NP001137569; and Human, AAL48218. The sequence of the signal
peptide is not shown. The column on the right shows the number of amino
acid residues in each CRP. (A) Sequence of amino acid residues 1–87 of
human CRP aligned with the sequence of CRP from other animals. Conserved
amino acid residues in the following functional sites are highlighted: The
intrinsically disordered region in CRP (amino acid residues 35–46 in human
CRP) is highlighted in red. The PCh-binding site (amino acid residues 66, 76,
and 81 in human CRP) is highlighted in blue. (B) Sequence of amino acid
residues 88–206 of human CRP aligned with the sequence of CRP from other
animals. Conserved amino acid residues in the following functional sites are
highlighted: The C1q-binding site (amino acid residues 112 and 175 in human
CRP) is highlighted in green. The Ca2+ -binding site (amino acid residues
134–148 in human CRP) is highlighted in yellow.

CRP IN A MOLLUSC
Based on the reactivity with anti-Limulus CRP antibodies, CRP
was detected in the hemolymph of the mollusc, giant African
snail, Achatina fulica (14, 15, 60–62). Achatina CRP binds to PCh
in a Ca2+ -dependent manner. The molecular weight of Achatina
CRP is ∼400 kDa. Achatina CRP is glycosylated and has two types
of subunits, of molecular weight 20 and 24 kDa. Although antiLimulus CRP antibodies react with Achatina CRP, anti-Achatina
CRP antibodies do not react with Limulus CRP. Achatina CRP
is a constitutively expressed protein and one of the major
components of the haemolymph with a normal level of ∼2.0
mg/ml. Like Limulus CRP, Achatina CRP has also been shown to
bind to heavy metals and it has been proposed that Achatina CRP
may be utilized as a viable exogenous agent of cytoprotection
against heavy metal-related toxicity. In addition, Achatina CRP
has been found to be bacteriostatic against gram negative bacteria
and bactericidal against gram positive bacteria (14, 15, 60–62).

CRP IN FISH
CRP was first found in the serum of a marine teleost fish,
plaice, Pleuronectes platessa (16–19) and has been isolated and
characterized mostly from teleost fish. Plaice CRP binds to
PCh in a Ca2+ -dependent manner and looks pentameric in its
electron microscopic appearance. The molecular weight of plaice
CRP is ∼187 kDa, consisting of 10 non-covalently associated
subunits arranged in two pentameric discs. There are two distinct
subunits in plaice CRP; the difference in size between the
subunits is due to carbohydrates since the heavier subunit is
glycosylated while the lighter one is not. Plaice CRP is present
at a concentration of 55 µg/ml and is not an acute phase protein
because its serum concentration does not increase in response
to turpentine. However, adrenal hormones and endotoxins do
cause an increase in circulating CRP in plaice (16–19). A CRP-like
protein has also been purified from the eggs of another marine
teleost, lumpsucker, Cyclopterus lumpus (20, 21). The molecular
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TABLE 1 | Properties of CRP isolated from various animals. See the text for scientific names of the animals.
Animal

Approximate molecular
weight (kDa)

Symmetry
(quaternary
structure)

Approximate
molecular of
subunits (kDa)

Horseshoe crab

300

Hexamer
(stack of two
hexamers)

25

Yes

No

(10–13)

Giant African Snail

400

20 and 24

Yes

No

(14, 15)

Plaice

187

18.7

Yes

No

(16–19)

26.6

Yes

Yes

Pentamer

22–29

Yes

24

No

Lumpsucker
Rainbow trout

125–150
81.4

Cod

Pentamer (10
subunits)
Pentamer

120

Pentamer

Channel catfish

100

Pentamer

Striped catfish

20–21.5

Trimer

Eel

28

Ayu
Pentamer

Common carp
Major carp
Goldfish
Dogfish
Zebrafish

Pentamer of dimers

Rockfish

(29)

Yes

(30)

27

Yes

Yes

(31)

22 and 29

Yes

Yes

(32, 33)

Yes

Dog

115

Pentamer

Harbor seal

(39)

Yes

(40)

No

(41)

23

No

No

(42, 43)

21

Yes

Yes

(44, 45)

25
120

Pentamer

(37, 38)

Yes

24
Pentamer

(34)
(35, 36)

Yes

30 and 26

100

Horse

Yes

Yes

Yes

Frog

Goat

No

33

26
160 and 152

(27)
(28)

25.2

Trimer

Cow

(25, 26)
Yes

25

Tonguefish

(22)
(23, 24)

Yes

25.6
250

References

(20, 21)

No

Trimer

Rohu

Glycosylation Acute phase
protein

Yes

(46)
(47)

24

Yes

No

118

Pentamer

24

No

Yes

(48)

Hamster

128–150

Pentamer

27–30

Yes

Yes

(49–51)

Rabbit

115–140

Pentamer

23.5

No

Yes

(52, 53)

Rat

129

Pentamer

23

Yes

Yes

(54)

Human

115

Pentamer

23

No

Yes

(55)

CRP has a molecular weight of ∼250 kDa with subunits of
molecular weight of ∼25 kDa. Dogfish CRP probably exists as
pentamers of two disulfide-linked dimers; however, the crystals
of the protein were found to contain two hexamers in the
asymmetric unit. Dogfish CRP is present at a concentration of
400 µg/ml. Dogfish CRP exhibits immunological cross-reactivity
with rabbit CRP. The CRP gene from zebrafish, Danio rerio,
a bony fish, has been cloned, expressed, protein purified, and
crystallized (37, 38, 74, 75). There are seven CRP-like genes
in zebrafish which are differentially expressed both normally
and in acute phase and have anti-viral activities. Zebrafish CRP
is trimeric, and each subunit has 208 amino acid residues.
In tonguefish, a flat fish, CRP is composed of 210 amino
acid residues with a subunit molecular weight of ∼26 kDa
(39). Expression of tonguefish CRP is upregulated by pathogen
infection. Tonguefish CRP has been found to interact with both
gram positive and negative bacteria.
In rockfish, Sebastes taczanowskii, CRP is a sex-limited protein
(40). CRP is induced in the serum of males by estrogen
administration. Serum levels in females during vitellogenic and

health status in cultured carp. Serum level of CRP in common
carp infected with some but not all pathogens increases severalfold, suggesting that common carp CRP is a minor acute phase
protein. CRP has also been purified from the sera of major
carp Catla catla (32, 33). Kinetic studies of metal intoxication
in major carp indicated that a unique molecular variant of
CRP is present in the serum at the peak level of acute phase
induction, and this variant coexists with normal CRP. Major carp
CRP is a glycoprotein, contains two non-identical subunits of
molecular weight 22 and 29 kDa, and binds to PCh in a Ca2+ dependent manner. The electrophoretic mobility of the subunits
is identical after desialylation and deglycosylation implying that
the molecular variants vary in the glycan parts. The expression
of CRP during the course of parasitic infection in the goldfish,
Carassius auratus, was also determined (34); goldfish CRP, which
has 214 amino acid residues and has subunits of 25.6 kDa,
enhances complement-mediated killing of trypanosomes in vitro,
and lysis increases after addition of immune serum.
Dogfish, Mustelus canis, CRP also binds to PCh in a Ca2+ dependent manner and precipitates PnC (35, 36, 73). Dogfish
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TABLE 2 | Immunological cross-reactivity among CRP from various animals.
Reactivity with serum or CRP

Anti-CRP antibodies or antiserum
Human

Human

Sheep

Rabbit

Dog

√

Sheep

Cow
√

√

Goat

Horseshoe crab

√

√

√

Rabbit

√

Dog

√

Cow

√

√

√

Goat

√

√

√

√

√
√

Rat
Mouse

√

Elephant

√

Horse

√

Monkey

√

Cat

√

Sheep

√

√

Dogfish

√
√

Snail
Horseshoe crab

√
√

√

√

Only those animals are shown for which at least one immunological cross-reactivity is known. See the text for references.

CRP IN MAMMALS

gestation periods are about 1,000 times higher than those in
the normal males. In the presence of Ca2+ , rockfish CRP
binds to PCh and agglutinates S. pneumoniae. In rockfish,
two types of CRP are found, with molecular weights 160
and 152 kDa, with subunits of 30 and 26 kDa, respectively.
Both subunits are glycosylated. In another species of rockfish,
Sebastes schlegelii, CRP contains 208 amino acid residues
with a molecular weight of 25 kDa (76). In Atlantic salmon
Salmo salar, five CRP-like molecules are present (77). Salmon
CRP has 208 amino acid residues, is not an acute phase
protein, and only one of five CRP species is upregulated
by cytokines.

CRP from cow, Bos taurus, has been purified from the serum
(42, 43, 80). Unlike human CRP, bovine CRP does not precipitate
PnC. However, bovine CRP exhibits immunological crossreactivity with human, goat and sheep CRP. Bovine CRP is
a pentameric molecule with a molecular weight of ∼100 kDa
and is composed of five identical non-glycosylated subunits of
molecular weight of ∼23 kDa. Each subunit has one intrachain
disulfide bond. The pentameric structure of bovine CRP was
seen by electron microscopy. The concentration of bovine CRP
is in the range of 5–40 µg/ml and it is not an acute phase
protein (42, 43, 80).
CRP from dogs, Canis lupus, exhibits Ca2+ -dependent
binding to PCh (44, 45, 81–88). Dog CRP has the typical
cyclic pentameric disc-like structure in its electron microscopic
appearance, although the pentamer stacks. Dog CRP has 204
amino acid residues and a molecular weight of ∼100 kDa. Dog
CRP is composed of five subunits of ∼20 kDa with an intrachain
disulfide bond in each subunit. In another study, the molecular
weight of dog CRP was estimated to be ∼156 kDa. In one study,
two isotypes of CRP with different molecular weights, 22 and 25
kDa were found, with the 25 kDa subunit glycosylated. Two of
the five subunits in the pentamer were glycosylated. Antibodies
to human CRP react with dog CRP, but antibodies to dog CRP
do not react with human CRP. However, antibodies to dog CRP
was used to detect CRP in elephants. CRP Normal healthy dogs
contain ∼5–60 µg/ml of CRP but, following a stimulus, CRP
behaves as an acute phase protein (44, 45, 81–88).
Guinea pig CRP has 206 amino acid residues and has not
been characterized fully, but the gene has organization typical
of the CRP genes of other mammals. Guinea pig CRP is not
an acute phase protein (89). Harbor seal, Phoca vitulina, CRP

CRP IN BIRDS, REPTILES,
AND AMPHIBIANS
So far, the presence of CRP has been investigated only in
the fowl Gallus gallus. In chickens, CRP has 206 amino acid
residues. The mRNA for CRP was found in many tissues
from the fowl by using a probe derived from human CRP
cDNA (78, 79). Although genes are present in lizards, the
CRP protein has not been isolated and characterized from any
reptile (77). Among amphibians, CRP has been isolated from
the frog Xenopus laevis (41). Frog CRP has 210 amino acid
residues. Xenopus CRP is present at an intermediate low level
of ∼1 µg/ml in the normal serum. Frog CRP level in the serum
is not induced by turpentine. It is suggested that frog CRP
represents a transitional period in the evolution of CRP, when
host defenses switched from primitive innate immunity to the
immune system. The constitutive functions of CRP gradually
became less essential as a result of the development of a complex
immune system (41).
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binds to PCh in a Ca2+ -dependent manner and has a molecular
weight of ∼25 kDa (46). A CRP-like protein has also been
isolated from goat serum (47). Direct binding of goat CRP to
PCh has not been shown; however, fluid phase PCh inhibits the
Ca2+ -dependent binding of goat CRP to its ligand agarose. Goat
CRP is composed of five identical, glycosylated, non-covalently
associated subunits, each of molecular weight ∼24 kDa. Goat
CRP possesses immunological cross-reactivity with human, cow
and sheep CRP. Like in cows and guinea pigs, CRP in goats is
not an acute phase protein (47). CRP in horses has pentameric
structure as revealed by electron microscopy and binds to PCh
in a Ca2+ -dependent manner (48, 90). Horse CRP has 204
amino acid residues and a molecular weight of ∼118 kDa. Horse
CRP is composed of five identical, non-glycosylated and noncovalently associated subunits with molecular weight of ∼23
kDa. Equine CRP displays immunochemical cross-reactivity with
human CRP. In horses, CRP is an acute phase protein (48, 90).
Monkey CRP has 206 amino acid residues and precipitates PnC;
however, monkey CRP was first isolated by Ca2+ -dependent
binding to organic monophosphates. Monkey CRP reacts with
anti-sheep CRP antibodies but not with anti-dog CRP antibodies
(91). CRP from pigs has 203 amino acid residues but not been
characterized fully yet. Porcine CRP is an acute phase protein
(92, 93).
A CRP-like protein named female protein (FP) was found
in Syrian and Armenian hamsters (49–51, 94–96). FP is a
prominent serum constituent of normal female hamsters but is
under hormonal control in males. However, in normal adult
male hamsters, FP in serum increases only about 5-fold during
an acute phase response, in contrast to human CRP which may
increase 1,000-fold or more. FP has a pentameric structure as
indicated by electron microscopy and binds to PCh in a Ca2+ dependent manner. FP has 206 amino acid residues with a
molecular weight in the range of 128–150 kDa. The molecular
weight of each of the five non-covalantly assembled glycosylated
subunits is in the range of 26–30 kDa; each subunit contains
a single intrachain disulphide bond. In the presence of Ca2+ ,
FP aggregates, probably to form decamers (49–51, 94–96). In
mice (97–100), CRP is not an acute phase protein. Murine CRP
agglutinates several strains of gram-positive bacteria in vitro.
Murine CRP has 206 amino acid residues. Protein modeling has
demonstrated that adaptively selected amino acid residues in
murine CRP lie in the ligand-binding region and contact region
between subunits (97–100).
Rabbit CRP reacts with PCh and precipitates PnC in a
Ca2+ -dependent manner (52, 53, 91, 101–120). CRP was
found localized at sites of inflammation in rabbits and was
not observed at the inflammatory site before appearance in
the blood. The concentration of rabbit CRP in the serum is
∼1.5 µg/ml. Investigation of rabbit CRP provided evidence that
CRP molecules expressing a structure and antigenicity that are
distinct from native CRP occurs in vivo, and that such molecules
accumulate at sites of inflammation. Rabbit CRP has 205 amino
acid residues and is pentameric. The molecular weight of rabbit
CRP lies between 115–140 kDa. The subunit size is 23.5 kDa.
For precipitation of the PCh-ligands, only the binding of the
phosphoryl group of PCh to rabbit CRP is required, unlike
for human CRP where binding to both the phosphoryl and
Frontiers in Immunology | www.frontiersin.org

cationic groups of PCh are needed for precipitation. Transgenic
mice expressing rabbit CRP are partially protected from a lethal
challenge of endotoxin or platelet activating factor. Rabbit CRP
is capable of activating complement when bound to a ligand;
however, complement activation is not required to mediate
protection against either endotoxins or platelet activating factor.
Immobilized rabbit CRP binds to low-density lipoprotein (LDL)
also. In rabbits, CRP has been found associated with the
progression of atherosclerosis (52, 53, 101–120).
Rat CRP is unique when compared to CRP from other
mammalian species (54, 111, 112, 121–133). Rat CRP has
five subunits arranged as a cyclic pentamer and is the only
mammalian CRP which is glycosylated and contains a covalently
linked dimer in its pentameric structure. Rat CRP binds to PCh
in a Ca2+ -dependent manner but does not precipitate PnC. The
non-glycosylated rat CRP is also able to bind to PCh. Rat CRP is
made up of 206 amino acid residues. One pair of the subunits per
molecule is linked by two interchain disulphide bonds, that is, the
five subunits are not non-covalently associated. The other three
subunits have intrachain disulfide bonds. Rat CRP is present at a
concentration of 0.3–0.5 mg/ml and is not an acute phase protein.
Immobilized rat CRP is capable of binding to LDL also in a Ca2+ dependent and PCh-inhibitable manner; however, the binding
ability of rat CRP to PCh is not a sufficient requirement for the
interaction between rat CRP and LDL. A sialic acid moiety must
also be present on rat CRP for binding to LDL. LDL is modified
once it is complexed with rat CRP. Like Limulus CRP, rat CRP has
also been shown to play a role in detoxification of heavy metals
such as mercury (54, 111, 112, 121–133).
Mink presents an unusual case (134): it is called mink SAP.
However, mink SAP is not glycosylated unlike SAP in other
mammals. Mink SAP binds to PCh also, unlike SAP in other
mammals. The molecular weight of mink SAP subunits is ∼26
kDa. The presence of mRNA for CRP has also been found by
using a probe derived from human CRP cDNA in many tissues
from Asian elephant Elephas maximus (135, 136) and ground
squirrel Spermophilus richarsonii (137). CRP is also present in
elephant seal Mirounga angustirostris (138). A gene sequence for
CRP is also found in marsupial genome, red-tailed phascogale
Phascogale calura (139).

HUMAN CRP
In humans, CRP is a major acute phase protein whose
concentration may increase more than 1,000-fold in severe
inflammatory states (9). Human CRP is a pentameric protein
composed of five identical non-covalently bound subunits of 206
amino acid residues with a molecular weight of ∼23 kDa. Human
CRP binds to PCh in a Ca2+ -dependent manner. There are five
PCh-binding sites, one located on each subunit. Each subunit
binds two Ca2+ ions (55, 140). In human CRP, Glu81 in the
PCh-binding site interacts with the nitrogen atom of choline
in PCh, Phe66 interacts with three methyl groups of choline,
and Thr76 is critical for creating the appropriately sized pocket
to accommodate PCh. The phosphate group of PCh directly
coordinates with the two Ca2+ bound to CRP. Using synthetic
peptides derived from CRP, direct binding of Ca2+ to a peptide
of residues 134–148 has been shown. Crystallography of CRP
6
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has demonstrated that two Ca2+ ions are co-ordinated by Asp60 ,
Asn61 , and by residues Glu138 , Gln139 , Asp140 , Glu147 , and Gln150
in a loop (55, 141–144). Once CRP is bound to a PCh-containing
ligand, it activates the classical complement pathway. Residues
Asp112 and Tyr175 play critical roles in the formation of the
C1q-binding site in CRP (145–147).
Acidic pH transforms native pentameric CRP into another
pentameric configuration, called as non-native CRP, which
exposes a hidden ligand-binding site for non-PCh ligands, and
which enables CRP to bind to immobilized, denatured and
aggregated proteins. For example, CRP does not bind to oxidized
LDL (ox-LDL) at physiological pH but gains the ability to bind to
ox-LDL at acidic pH (148). H2 O2 -treated CRP also gains a ligand
recognition property not exhibited by native CRP, indicating that
H2 O2 , like acidic pH, is another modifier of the structure and
ligand recognition function of CRP (149). Immobilization of CRP
or mutagenesis of Glu42 in the inter-subunit contact region in
pentameric CRP also convert CRP into molecules that bind to a
variety of immobilized, denatured and aggregated proteins (148–
151). A possible binding site in non-native CRP for immobilized,
denatured and aggregated proteins could be formed involving
the single intrinsically disordered region present in CRP (152).
It has been shown that when CRP dissociates into its monomers,
monomeric CRP recognizes such protein ligands through the
intrinsically disordered region (152).
CRP is a multifunctional component of the human innate host
defense machinery. In mouse models of pneumococcal infection,
transgenic or passively administered human CRP has been shown
to be protective against lethal infection with S. pneumoniae (153–
160). Similarly, CRP may be an atheroprotective molecule, as
shown by using transgenic CRP in animal models of human
like atherosclerosis (161–166). CRP has been found deposited at
sites of inflammation, indicating the presence of non-native CRP
in vivo. The functions of CRP at sites of inflammation have not
been defined yet; however, it has been suggested that a structural
change in CRP and the resulting shift from the ligand recognition
function of CRP in its native conformation to another ligand
recognition function in its non-native conformation occurs at
sites of inflammation (151, 152, 167).
Interestingly, human CRP also possesses sites for
glycosylation, although the sites are hidden in native CRP (168–
170). When CRP was isolated from patients with six different
pathological conditions, CRP was found to be differentially
glycosylated. A few amino acids at the N-terminus and a few
amino acids near the C-terminus are missing in glycosylated
human CRP. The cleavage of these peptides from CRP exposes
two potential sites of glycosylation and these sites are located
on CRP on the face opposite to the PCh-binding face of CRP. It
has been proposed that glycosylated CRP has a protective role
toward the clearance of damaged erythrocytes in diseases.

in invertebrates. For invertebrates, it has always been difficult to
define a protein as either CRP or SAP because of the similarities
in their structures and functions. Also, whereas a single CRP
gene is present in the human, multiple genes are present in some
species, such as Limulus.
There is sequence similarity and homology among the
known functional sites of CRP from all species (Figure 1). The
PCh-binding property of CRP has been conserved. However,
employing animal models of pneumococcal infection it has
been shown that the PCh-binding property of human CRP is
not the only relevant ligand recognition function of human
CRP. Apparently, another ligand-binding property of CRP,
such as recognition of complement regulator protein factor
H by CRP in its non-native conformation, is responsible for
its host defense functions (160). Because some ancient CRP
molecules including bovine CRP do not bind PCh, it has
been proposed that the recognition of PCh by CRP is less
relevant to the role of the protein than its interaction with other
ligands (42, 151, 160).
Human CRP in its non-native structural conformation
expresses the capability to bind to deposited and
conformationally altered proteins and which can be achieved
by several means including treatment of CRP with acidic pH
(151). The ligand-binding property of human CRP in its nonnative structure has implications for toxic and inflammatory
conditions and favors the conservation of CRP throughout
evolution. It seems that the host-defense functions of CRP
evolved to expose a ligand-binding site only when needed,
that is, an inflammatory microenvironment would have to be
sensed by CRP first and that CRP would change its structure
to execute a function. It is not known, however, whether CRP
from invertebrates also exhibits structure-based ligand-binding
properties. A recent study has shown that Limulus CRP is capable
of binding to immobilized ox-LDL without being pre-treated
with acidic pH (171). During evolution, changes in the intrachain
disulfide and interchain disulfide bonds and the changes in the
glycosylation status of CRP may also be responsible for the
structure-function relationships of CRP in various species.

CONCLUSIONS
CRP evolved as a component of and along with the development
of the entire immune system. Both structure and function of
CRP have evolved; however, more studies on CRP from all
invertebrates and vertebrates are needed to understand fully
the reasons behind the evolution of CRP. Structure-function
relationships of CRP from most animals are unknown. We
know that the ligand-binding properties of Limulus CRP are
not identical to that of native human CRP but overlap the
ligand-binding properties of non-native pentameric human CRP
that can be generated at inflammatory microenvironments (143,
158). Since the ligand recognition functions of CRP lead to
effector functions, it is important to understand the biology
of ancient CRP molecules because the knowledge could be
useful for immunodeficient individuals: all humans have CRP,
but it is not known whether human CRP is functional in
all humans.

EVOLUTION OF CRP
As the nature of CRP gene expression evolved from a
constitutively expressed protein in arthropods to an acute
phase protein in humans, the definition of CRP also became
distinctive. In humans, CRP can easily be distinguished from
other homologous proteins such as SAP, but this is not the case
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